logo
Top Stories
56
45
Apple-072616-lg.jpg

Shares of Apple Inc. (AAPL) gained 5 percent in extended trading session after the tech giant reported a third-quarter profit and revenues that trumped Wall Street expectations driven by higher-than-expected iPhone sales. Although, Apple reported its...

Consumer prices in Australia were up 1.0 percent on year in the second quarter of 2016, the Australian Bureau of Statistics said on Wednesday. That was shy of forecasts for 1.1 percent and down from 1.3 percent in the three months prior. On a quarterly...

DonaldTrump-Meeting1-072516-lg.jpg

On the heels of last week's Republican National Convention, the results of a new CNN/ORC poll show that GOP presidential nominee Donald Trump has jumped into the lead over likely Democratic nominee Hillary Clinton.

Asian-Markets1_26Jul16.jpg

Asian stock markets are mostly higher on Wednesday, with the Japanese market staging a rebound following three straight days of losses. However, gains are modest in most markets as investors treaded cautiously ahead of the U.S. Federal Reserve's interest...

cleo-072616-lg.jpg

Television personality, Miss Cleo, who was famous for her alleged psychic abilities, has died at the age of 53. Miss Cleo, was born Youree Harris in Los Angeles, California. She had been battling colon cancer. On Tuesday morning at a hospice center...

The number of drug resistant cases of gonorrhea have increased in the U.S. in recent years, according to a new study from researchers at the Centers for Disease Control and Prevention. The agency released an official statement earlier this week noting...

Asian-Markets2_20Jul16.jpg Stock futures point a flat open on Wednesday as global equities show signs of fatigue amid concerns about slowing global growth, mixed earnings reports and heightened concerns about global geopolitical risk. U.S. stocks ended mixed overnight, as investors...
AMD-EP-072016.jpg Advanced Micro Devices Inc. (AMD) is likely to release its second-quarter numbers after the bell on Thursday, July 21, with analysts polled by Thomson Reuters estimating a loss of $0.08 per share on revenue of $951.61 million. Analysts' estimate typically exclude certain special items.
Pharma-071916.jpg Shares of Zafgen Inc. (ZFGN) plunged over 40% in extended trading on Tuesday, after the company announced that it is suspending the development of its drug candidate Beloranib in Prader-Willi syndrome.
ASML-072016.jpg Dutch semiconductor equipment maker ASML Holding NV reported Wednesday a decline in the second-quarter profit on weak margin. However, net sales increased on higher system sales, despite lower pricing. Looking ahead, the company expects sequentially higher margin and lower sales in its third quarter. It also expects full-year 2016 sales to exceed 2015 record year.
More
DonaldTrump-Meeting1-072516.jpg On the heels of last week's Republican National Convention, the results of a new CNN/ORC poll show that GOP presidential nominee Donald Trump has jumped into the lead over likely Democratic nominee Hillary Clinton.
More
CapitolDome-072216.jpg Suggesting Republican presidential nominee Donald Trump and other Americans are embracing his ideas, former Ku Klux Klan leader David Duke announced Friday that he is running for U.S. Senate in Louisiana.
More
UKManufacturing-072516.jpgBritish business confidence plunged to its lowest level in seven-and-a-half years, after the surprise "Brexit" vote, survey results from the Confederation of British Industry (CBI) showed Monday. The quarterly CBI Industrial Trends survey showed that 52 percent of firms were less optimistic about the general business situation than three months ago, while 5 percent said they were more optimistic.
More
The number of drug resistant cases of gonorrhea have increased in the U.S. in recent years, according to a new study from researchers at the Centers for Disease Control and Prevention. The agency released an official statement earlier this week noting that "the future of current treatment options may be in jeopardy."
More
The Japanese stock market is rising on Wednesday after three straight days of losses, despite the mixed cues from Wall Street. In addition, the weaker yen boosted exporters' shares. In late-morning trades, the benchmark Nikkei 225 Index is advancing 207.27 points or 1.27 percent to 16,590.31, off...
Bristol-Myers Squibb Co. (BMY) announced Tuesday a new clinical research collaboration with Janssen Biotech, Inc. in Immuno-Oncology focused on lung cancer. The companies would evaluate Bristol-Myers' Immuno-Oncology or I-O agent Opdivo (nivolumab)... More
Turkey has arrested 6,000 people after a failed coup, with President Erdogan vowing to purge state bodies of the "virus" that caused the revolt. Erdogan's top military aide Col Ali Yazici is among those now in custody. The overall death toll for...
More
GoogleMap-072616.jpg Google maps will be more easy to use with its latest update. Traffic information will be more visible with its new cleaner look.
More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
07/26/16 21:30CPI (Q-o-Q)Q2 Australia
07/26/16 21:30CPI (Y-o-Y)Q2 Australia
07/26/16 21:30Trimmed Mean (Q-o-Q)Q2 Australia
07/26/16 21:30Trimmed Mean (Y-o-Y)Q2 Australia
07/26/16 21:30Weighted Median (Q-o-Q)Q2 Australia
07/26/16 21:30Weighted Median (Y-o-Y)Q2 Australia
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
10/23/16MRKBezlotoxumab (BLA)FDA decision on Bezlotoxumab for prevention of C. difficile infection recurrence
10/22/16MDVNXTANDI (sNDA)FDA decision on XTANDI in metastatic castration-resistant prostate cancer with data from head-to-head studies of Enzalutamide Vs Bicalutamide
10/22/16OPKRAYALDEE (NDA Resubmission)FDA decision on RAYALDEE for the treatment of secondary hyperparathyroidism in adult patients with stage 3 or 4 CKD and vitamin D insufficiency.
10/19/16RHHBYAtezolizumab (BLA)FDA decision on Atezolizumab for the treatment of specific type of lung cancer
10/19/16AGNSER120 (low-dose desmopressin nasal spray) NDAFDA panel to review SER120 for the treatment of adult onset nocturia
Complete FDA Calendar